78 related articles for article (PubMed ID: 22461171)
1. Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor.
Godoi LC; Gomes KB; Alpoim PN; Carvalho Md; Lwaleed BA; Sant'Ana Dusse LM
J Thromb Thrombolysis; 2012 Jul; 34(1):1-6. PubMed ID: 22461171
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor and its natural inhibitor in pre-eclampsia and SGA.
Erez O; Romero R; Hoppensteadt D; Than NG; Fareed J; Mazaki-Tovi S; Espinoza J; Chaiworapongsa T; Kim SS; Yoon BH; Hassan SS; Gotsch F; Friel L; Vaisbuch E; Kusanovic JP
J Matern Fetal Neonatal Med; 2008 Dec; 21(12):855-69. PubMed ID: 19065458
[TBL] [Abstract][Full Text] [Related]
3. High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor.
Erez O; Romero R; Vaisbuch E; Kusanovic JP; Mazaki-Tovi S; Chaiworapongsa T; Gotsch F; Fareed J; Hoppensteadt D; Than NG; Yoon BH; Edwin S; Dong Z; Espinoza J; Mazor M; Hassan SS
J Matern Fetal Neonatal Med; 2010 Jan; 23(1):23-33. PubMed ID: 19883261
[TBL] [Abstract][Full Text] [Related]
4. Endothelial dysfunction in the pathogenesis of pre-eclampsia in Ghanaian women.
Adu-Bonsaffoh K; Antwi DA; Gyan B; Obed SA
BMC Physiol; 2017 Mar; 17(1):5. PubMed ID: 28356151
[TBL] [Abstract][Full Text] [Related]
5. Association of prothrombin time, thrombin time and activated partial thromboplastin time levels with preeclampsia: a systematic review and meta-analysis.
Alemayehu E; Mohammed O; Belete MA; Mulatie Z; Debash H; Gedefie A; Weldehanna DG; Eshetu B; Shibabaw A; Tekele SG; Tilahun M; Ebrahim H
BMC Pregnancy Childbirth; 2024 May; 24(1):354. PubMed ID: 38741046
[TBL] [Abstract][Full Text] [Related]
6. Is ELABELA a reliable biomarker for hypertensive disorders of pregnancy?
Huang R; Zhu J; Zhang L; Hua X; Ye W; Chen C; Sun K; Wang W; Feng L; Zhang J;
Pregnancy Hypertens; 2019 Jul; 17():226-232. PubMed ID: 31487645
[TBL] [Abstract][Full Text] [Related]
7. The Relationship between the Level of Coagulative Function Hypertensive Disorder Complicating Pregnancy.
Lin Z; Fang B; Zhu D; Wang D; Lin X; Yu X; Wang F; Yang C
Niger J Clin Pract; 2024 May; 27(5):599-603. PubMed ID: 38842709
[TBL] [Abstract][Full Text] [Related]
8. Coagulation Factors and Natural Anticoagulants as Surrogate Markers of Preeclampsia and Its Subtypes: A Case-Control Study in a Ghanaian Population.
Mintaah S; Anto EO; Boadu WIO; Sackey B; Boateng LA; Ansah E; Korsah EE; Frimpong J; Tamakloe VCKT; Selleh PK; Afrifa DA; Saasi AR; Senu E; Duah LA; Opoku S; Amoah JP; Adu P; Boachie J; Nyamekye DA; Sackey DS; Wiafe YA; Addai-Mensah O
Clin Appl Thromb Hemost; 2023; 29():10760296231204604. PubMed ID: 37787124
[TBL] [Abstract][Full Text] [Related]
9. Multiprofessional care promotes of quality of life in pregnant women with preeclampsia: a cross-sectional study.
Machado MSR; Bertagnolli TV; Veiga ECA; Ferreira CJH; Duarte G; Machado JSR; Carvalho R
Clinics (Sao Paulo); 2020; 75():e1951. PubMed ID: 33146357
[TBL] [Abstract][Full Text] [Related]
10. Changes in the autonomic cardiorespiratory activity in parturient women with severe and moderate features of preeclampsia.
Pichardo-Carmona EY; Reyes-Lagos JJ; Ceballos-Juárez RG; Ledesma-Ramírez CI; Mendieta-Zerón H; Peña-Castillo MÁ; Nsugbe E; Porta-García MÁ; Mina-Paz Y
Front Immunol; 2023; 14():1190699. PubMed ID: 37724103
[TBL] [Abstract][Full Text] [Related]
11. Maternal serum angiopoietins levels in pre-eclampsia and pregnancy outcomes.
Bayor F; Adu-Bonsaffoh K; Antwi-Boasiako C
Health Sci Rep; 2024 Jan; 7(1):e1806. PubMed ID: 38226360
[TBL] [Abstract][Full Text] [Related]
12. Plasma tissue factor pathway inhibitor levels in coronavirus disease 2019 patients: a systematic review and meta-analysis.
Hassani S; Sayyadi M; Almasi-Hashiani A
Blood Coagul Fibrinolysis; 2024 Jun; 35(4):196-205. PubMed ID: 38625831
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal observations of TFPI levels in paediatric Haemophilia A patients.
Schwers S; Shah A; Linardi C; Zhang Y; Willmann S
Haemophilia; 2023 Jul; 29(4):1142-1149. PubMed ID: 37335569
[TBL] [Abstract][Full Text] [Related]
14. Increased contact activated endogenous thrombin potential in pregnant women with preeclampsia.
Godtfredsen AC; Palarasah Y; Dolleris BB; Jørgensen JS; Sidelmann JJ; Gram JB
Blood Coagul Fibrinolysis; 2024 Jan; 35(1):1-7. PubMed ID: 38051647
[TBL] [Abstract][Full Text] [Related]
15. GPIbα reflects the development and progress of the patients with severe preeclampsia.
Wu FJ; Zheng MY; Liu LL; Wang DD; Ma XY
Int J Clin Exp Med; 2015; 8(4):6039-45. PubMed ID: 26131201
[TBL] [Abstract][Full Text] [Related]
16. Is the central complement component C3 altered in the synergy of HIV infection and preeclampsia?
David M; Singh S; Naicker T
Eur J Obstet Gynecol Reprod Biol X; 2023 Dec; 20():100257. PubMed ID: 37885814
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor activity in women with preeclampsia or SGA: a potential explanation for the excessive thrombin generation in these syndromes.
Erez O; Romero R; Vaisbuch E; Than NG; Kusanovic JP; Mazaki-Tovi S; Gotsch F; Mittal P; Dong Z; Chaiworapongsa T; Kim CJ; Nhan-Chang CL; Kim SK; Yeo L; Mazor M; Hassan SS
J Matern Fetal Neonatal Med; 2018 Jun; 31(12):1568-1577. PubMed ID: 28521572
[TBL] [Abstract][Full Text] [Related]
18. Hemostasis in Pre-Eclamptic Women and Their Offspring: Current Knowledge and Hemostasis Assessment with Viscoelastic Tests.
Kontovazainitis CG; Gialamprinou D; Theodoridis T; Mitsiakos G
Diagnostics (Basel); 2024 Feb; 14(3):. PubMed ID: 38337863
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred study.
Di Bartolomeo A; Chauleur C; Gris JC; Chapelle C; Noblot E; Laporte S; Raia-Barjat T
PLoS One; 2017; 12(3):e0173596. PubMed ID: 28328938
[TBL] [Abstract][Full Text] [Related]
20. A Dormant Microbial Component in the Development of Preeclampsia.
Kell DB; Kenny LC
Front Med (Lausanne); 2016; 3():60. PubMed ID: 27965958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
